A Multicenter Two-arm, Phase II Trial Assessing the Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer (ABLATE, KCSG-LU21-11)
Kyung Hwan Kim, Shinkyo Yoon, Hee Kyung Ahn, Seo Young Lee, Gyeong Won Lee, Sung Sook Lee, Jang Ho Cho, Byoung Chul Cho, Hong In Yoon, Sun Min Lim
Dive into the research topics of 'A Multicenter Two-arm, Phase II Trial Assessing the Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer (ABLATE, KCSG-LU21-11)'. Together they form a unique fingerprint.